FrostPharma strengthens product portfolio with deal of 5 additional hospital pharmaceuticals
FrostPharma has entered an agreement with STEROP, bringing 5 additional products to the current FrostPharma portfolio. The deal encompasses commercial rights, including distribution and market authorization rights for the included products.